检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Add-On Parsaclisib (A Pi3k Delta Inhibitor) In Patients With Myelofibrosis And Suboptimal Response To Ruxolitinib: Interim Analysis From A Phase 2 Study

Abdulraheem Yacoub,Uma Borate,Raajit Rampal,Haris Ali,Eunice Wang,Aaron Gerds,Gabriela Hobbs,Marina Kremyanskaya,Elliott Winton,Casey O'Connell,Swati Goel,Stephen Oh,Gary Schiller,Albert Assad,Sue Erickson-Viitanen,Xuejun Chen,Feng Zhou,Naval Daver

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2021）

引用 8|浏览16
暂无评分
关键词
MPN, myelofibrosis, phase 2, PI3K, ruxolitinib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要